Drug Type Chemical drugs |
Synonyms |
Target |
Mechanism NTRK inhibitors(Neurotrophic tyrosine kinase receptor inhibitors), VEGFR antagonists(Vascular endothelial growth factor receptor antagonists), c-Met inhibitors(Hepatocyte growth factor receptor inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Inactive Organization- |
Drug Highest PhaseIND Approval |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Gastrointestinal Neoplasms | IND Approval | US | 29 Dec 2023 | |
Neoplasms | Discovery | CN | 02 Feb 2021 |